Cargando…
UBE2T-regulated H2AX monoubiquitination induces hepatocellular carcinoma radioresistance by facilitating CHK1 activation
BACKGROUND: Radioresistance is the major obstacle in radiation therapy (RT) for hepatocellular carcinoma (HCC). Dysregulation of DNA damage response (DDR), which includes DNA repair and cell cycle checkpoints activation, leads to radioresistance and limits radiotherapy efficacy in HCC patients. Howe...
Autores principales: | Sun, Jingyuan, Zhu, Zhenru, Li, Wenwen, Shen, Mengying, Cao, Chuanhui, Sun, Qingcan, Guo, Zeqin, Liu, Li, Wu, Dehua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576867/ https://www.ncbi.nlm.nih.gov/pubmed/33087136 http://dx.doi.org/10.1186/s13046-020-01734-4 |
Ejemplares similares
-
UBE2T-mediated Akt ubiquitination and Akt/β-catenin activation promotes hepatocellular carcinoma development by increasing pyrimidine metabolism
por: Zhu, Zhenru, et al.
Publicado: (2022) -
UBE2T regulates FANCI monoubiquitination to promote NSCLC progression by activating EMT
por: Zhang, Jiguang, et al.
Publicado: (2022) -
γH2AX and Chk1 phosphorylation as predictive pharmacodynamic biomarkers of Chk1 inhibitor-chemotherapy combination treatments
por: Rawlinson, Rebecca, et al.
Publicado: (2014) -
UBE2B promotes ovarian cancer growth via promoting RAD18 mediated ZMYM2 monoubiquitination and stabilization
por: Zeng, Xi, et al.
Publicado: (2022) -
ATR inhibitor AZD6738 enhances the antitumor activity of radiotherapy and immune checkpoint inhibitors by potentiating the tumor immune microenvironment in hepatocellular carcinoma
por: Sheng, Hailong, et al.
Publicado: (2020)